NanoViricides (NNVC) Competitors $1.03 -0.11 (-9.21%) As of 10:39 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock NNVC vs. EXOZ, AVTX, JSPR, CLSD, PYRGF, IGMS, ABOS, PYXS, AVTE, and GNTAShould you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include Exozymes (EXOZ), Avalo Therapeutics (AVTX), Jasper Therapeutics (JSPR), Clearside Biomedical (CLSD), PyroGenesis Canada (PYRGF), IGM Biosciences (IGMS), Acumen Pharmaceuticals (ABOS), Pyxis Oncology (PYXS), Aerovate Therapeutics (AVTE), and Genenta Science (GNTA). These companies are all part of the "pharmaceutical products" industry. NanoViricides vs. Exozymes Avalo Therapeutics Jasper Therapeutics Clearside Biomedical PyroGenesis Canada IGM Biosciences Acumen Pharmaceuticals Pyxis Oncology Aerovate Therapeutics Genenta Science Exozymes (NASDAQ:EXOZ) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Does the MarketBeat Community favor EXOZ or NNVC? Exozymes and NanoViricides both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformExozymesN/AN/ANanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% Which has stronger earnings & valuation, EXOZ or NNVC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExozymesN/AN/AN/AN/AN/ANanoViricidesN/AN/A-$8.29M-$0.72-1.44 Is EXOZ or NNVC more profitable? Exozymes' return on equity of 0.00% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets ExozymesN/A N/A N/A NanoViricides N/A -87.90%-78.69% Does the media refer more to EXOZ or NNVC? In the previous week, Exozymes had 3 more articles in the media than NanoViricides. MarketBeat recorded 3 mentions for Exozymes and 0 mentions for NanoViricides. NanoViricides' average media sentiment score of 1.00 beat Exozymes' score of 0.30 indicating that NanoViricides is being referred to more favorably in the news media. Company Overall Sentiment Exozymes Neutral NanoViricides Positive Do insiders and institutionals believe in EXOZ or NNVC? 10.3% of NanoViricides shares are owned by institutional investors. 4.6% of NanoViricides shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryExozymes and NanoViricides tied by winning 3 of the 6 factors compared between the two stocks. Remove Ads Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNVC vs. The Competition Export to ExcelMetricNanoViricidesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$16.19M$6.56B$5.40B$18.13BDividend YieldN/A2.85%4.87%3.79%P/E Ratio-1.446.8522.8830.20Price / SalesN/A194.91357.3024.52Price / CashN/A65.6738.1617.54Price / Book1.575.746.324.22Net Income-$8.29M$142.37M$3.21B$1.02B7 Day Performance-14.46%-9.71%-6.89%-7.43%1 Month Performance-14.46%-12.66%-1.87%-8.35%1 Year Performance-25.00%-16.65%4.62%-3.39% NanoViricides Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNVCNanoViricidesN/A$1.04-9.2%N/A-10.9%$16.19MN/A-1.4420Positive NewsGap DownEXOZExozymesN/A$13.11-11.5%N/AN/A$81.96MN/A0.0029Gap UpAVTXAvalo Therapeutics3.0506 of 5 stars$7.63-0.4%$35.33+363.1%-59.6%$79.31M$820,000.000.0040JSPRJasper Therapeutics2.7587 of 5 stars$5.24+0.6%$62.50+1,092.7%-85.2%$78.72MN/A-1.1120Positive NewsCLSDClearside Biomedical2.2403 of 5 stars$1.03+2.5%$5.75+458.3%-37.1%$78.12M$7.70M-2.2930Analyst RevisionGap DownPYRGFPyroGenesis CanadaN/A$0.40+2.5%N/A+11.5%$75.59M$9.14M-6.7590High Trading VolumeIGMSIGM Biosciences4.7304 of 5 stars$1.26+5.9%$5.50+336.5%-87.2%$75.32M$2.68M-0.35190ABOSAcumen Pharmaceuticals2.6412 of 5 stars$1.24+3.3%$9.33+652.7%-74.7%$74.50MN/A-0.9020Gap DownPYXSPyxis Oncology1.0583 of 5 stars$1.20-0.8%$9.20+666.7%-83.1%$73.91M$16.15M-1.1760Gap DownAVTEAerovate Therapeutics0.7361 of 5 stars$2.55+1.2%$2.25-11.8%-91.4%$73.63MN/A-0.8520News CoveragePositive NewsGNTAGenenta Science2.8914 of 5 stars$4.01-3.4%$25.00+523.4%+14.0%$73.34MN/A0.007 Remove Ads Related Companies and Tools Related Companies Exozymes Alternatives Avalo Therapeutics Alternatives Jasper Therapeutics Alternatives Clearside Biomedical Alternatives PyroGenesis Canada Alternatives IGM Biosciences Alternatives Acumen Pharmaceuticals Alternatives Pyxis Oncology Alternatives Aerovate Therapeutics Alternatives Genenta Science Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NNVC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NNVC Stock Free NNVC Stock Alerts